Evidence map›Paper›PMID 40308653›Full record

Article3D printing and additive manufacturing2025

Bioreactors as Additive Manufacturing Environments.

Orkan Telhan

Abstract read
In one paragraph

Article in 3D printing and additive manufacturing, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Orkan TelhanStuart Weitzman School of Design, University of Pennsylvania, Philadelphia, Pennsylvania, USA.ORCID https://orcid.org/0009-0000-0926-1547

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This article discusses the evolving use of bioreactors, beyond traditional life sciences and bioengineering, in fields such as architecture, fashion, and product design. It explores the role of bioreactors in additive fabrication, highlighting their distinct characteristics compared with conventional digital manufacturing. The discussion is centered on the differences in materializing biologically-active (living) versus biologically-passive, or biologically-derived (nonliving) matter in which ingredients require closed-loop fabrication environments that differ from traditional additive manufacturing tools. Two novel biofabrication platforms, Microbial Design Studio and B | reactor are presented as examples with case studies demonstrating their use in various manufacturing workflows with live cells. The article emphasizes the unique capabilities of bioreactors in engaging with living matter and facilitating complex interactions between biological, algorithmic, and mechanical systems in additive manufacturing.

Indexed as

biodesignbiological designbiomanufacturingbioreactorsclosed-loop manufacturing

Identifiers

PMID40308653
PMCPMC12038321

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.